POCI — Stock Film
STOCK FILMSCENE 1/11POCI · $4.30
Stock Expert AI presents
POCI
Precision Optics Corporation, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Precision Optics Corporation, Inc. A quick introduction.

On the stock market since 1992, it operates in the world of health and science. It has 90 employees. Now — the numbers.

on the stock market since 1992
90 employees
$33.2M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.3.

The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales are growing overall, with a pause along the way.

Average growth of 16% a year over the last 4 years. Red columns mark years that ended in a loss.

$10.7M
2021
$15.7M
2022
$21M
2023
$19.1M
2024
$19.1M
2025
In the vault right now:
$0
DEBT: $2.0M
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
46
weak

Clearly below the class average.

FINANCIAL STRENGTH
39
weak

Clearly below the class average.

VALUATION
67
strong

Clearly above the class average — a step short of the very top.

GROWTH
12
very weak

Clearly below the class average.

PRICE MOMENTUM
44
weak

Clearly below the class average.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 4 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Executives are buying stock8/10
WEAK SPOTS
The stock has lost its spark0/10
Each sale is made at a loss3/10
Costs eat into the margin4/10
WORTH WATCHING

Profit per Sale: Right now the product sells for less than it costs to make; every sale deepens the loss.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 44% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/2
The product is selling

Sales run at $19.1M a year. A small number, but proof the product has real buyers.

2
THE BRIGHT SIDE · 2/2
Executives are buying their own stock

Over the last 12 months, company executives reported 14 buys and 4 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/2
Small sales, big loss

A loss of $5.8M against $19.1M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
F
0 / 100 · MoonshotScore

On our five-subject report card, POCI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: POCI is a high-risk stock — not yet profitable, and its future rides on its product catching on.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film